BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18532911)

  • 1. LC-MS for protein characterization: current capabilities and future trends.
    Chen G; Pramanik BN
    Expert Rev Proteomics; 2008 Jun; 5(3):435-44. PubMed ID: 18532911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery.
    Chen G; Pramanik BN; Liu YH; Mirza UA
    J Mass Spectrom; 2007 Mar; 42(3):279-87. PubMed ID: 17295416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein glycosylation analysis by liquid chromatography-mass spectrometry.
    Wuhrer M; Deelder AM; Hokke CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):124-33. PubMed ID: 16213446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein N-glycosylation.
    Medzihradszky KF
    Methods Enzymol; 2005; 405():116-38. PubMed ID: 16413313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mining phosphopeptide signals in liquid chromatography-mass spectrometry data for protein phosphorylation analysis.
    Wu HY; Tseng VS; Liao PC
    J Proteome Res; 2007 May; 6(5):1812-21. PubMed ID: 17402769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides.
    Lin ZJ; Li W; Dai G
    J Pharm Biomed Anal; 2007 Jun; 44(2):330-41. PubMed ID: 17339091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated top-down and bottom-up strategy for characterization of protein isoforms and modifications.
    Wu S; Tolić N; Tian Z; Robinson EW; Paša-Tolić L
    Methods Mol Biol; 2011; 694():291-304. PubMed ID: 21082441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.
    Chen G; Warrack BM; Goodenough AK; Wei H; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2011 Jan; 16(1-2):58-64. PubMed ID: 21093608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging mass spectrometry-based technologies for analyses of chromatin changes: analysis of histones and histone modifications.
    Shah B; Kozlowski RL; Han J; Borchers CH
    Methods Mol Biol; 2011; 773():259-303. PubMed ID: 21898261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry for protein identification and the study of post translational modifications.
    Salzano AM; Crescenzi M
    Ann Ist Super Sanita; 2005; 41(4):443-50. PubMed ID: 16569912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the analysis of protein phosphorylation.
    Paradela A; Albar JP
    J Proteome Res; 2008 May; 7(5):1809-18. PubMed ID: 18327898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of quantitative LC-MS techniques for proteomics and activitomics.
    Timms JF; Cutillas PR
    Methods Mol Biol; 2010; 658():19-45. PubMed ID: 20839096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
    Srebalus Barnes CA; Lim A
    Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of post-translationally modified recombinant protein using liquid chromatography/mass spectrometry.
    Wu XD; Kircher RA; McVerry PH; Malinzak DA
    Dev Biol (Basel); 2000; 103():61-7. PubMed ID: 11214254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC/MS applications in drug development.
    Lee MS; Kerns EH
    Mass Spectrom Rev; 1999; 18(3-4):187-279. PubMed ID: 10568041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sherpa: a Macintosh-based expert system for the interpretation of electrospray ionization LC/MS and MS/MS data from protein digests.
    Taylor JA; Walsh KA; Johnson RS
    Rapid Commun Mass Spectrom; 1996; 10(6):679-87. PubMed ID: 8624418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in liquid chromatography-mass spectrometry and related techniques.
    Holčapek M; Jirásko R; Lísa M
    J Chromatogr A; 2012 Oct; 1259():3-15. PubMed ID: 22959775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical proteomics: current status, challenges, and future perspectives.
    Chiou SH; Wu CY
    Kaohsiung J Med Sci; 2011 Jan; 27(1):1-14. PubMed ID: 21329886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.